ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 133 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,299,500 | +59.9% | 90,000 | +50.0% | 0.04% | +28.6% |
| Q1 2023 | $1,438,200 | +29.6% | 60,000 | -20.0% | 0.03% | +86.7% |
| Q3 2022 | $1,110,000 | -5.9% | 75,000 | 0.0% | 0.02% | -11.8% |
| Q2 2022 | $1,180,000 | +340.3% | 75,000 | +650.0% | 0.02% | +466.7% |
| Q1 2022 | $268,000 | -27.6% | 10,000 | 0.0% | 0.00% | -25.0% |
| Q4 2021 | $370,000 | -22.6% | 10,000 | 0.0% | 0.00% | -20.0% |
| Q3 2021 | $478,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 8,394 | $264,663 | 0.19% |
| Global Wealth Strategies & Associates | 100 | $3,153 | 0.00% |